AFFIMED N V's ticker is AFMD and the CUSIP is N01045108. A total of 134 filers reported holding AFFIMED N V in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $327,000 | -32.9% | 118,200 | +6.0% | 0.00% | -50.0% |
| Q1 2022 | $487,000 | -20.8% | 111,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $615,000 | -10.7% | 111,500 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $689,000 | -27.2% | 111,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $947,000 | +28.8% | 111,500 | +19.9% | 0.00% | 0.0% |
| Q1 2021 | $735,000 | +35.9% | 93,000 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $541,000 | +84.0% | 93,000 | +7.0% | 0.00% | +100.0% |
| Q3 2020 | $294,000 | -26.7% | 86,900 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $401,000 | +220.8% | 86,900 | +9.0% | 0.00% | +100.0% |
| Q1 2020 | $125,000 | -42.7% | 79,700 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $218,000 | +78.7% | 79,700 | +91.6% | 0.00% | – |
| Q3 2019 | $122,000 | – | 41,600 | – | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2015 | $66,000 | – | 4,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Public Equity Management, LLC | 3,209,013 | $6,578,000 | 0.40% |
| Telemetry Investments, L.L.C. | 367,067 | $752,000 | 0.35% |
| NEA Management Company, LLC | 3,888,888 | $7,972,000 | 0.29% |
| DAFNA Capital Management LLC | 92,500 | $190,000 | 0.14% |
| Tekla Capital Management LLC | 1,405,324 | $2,881,000 | 0.11% |
| Perceptive Advisors | 668,214 | $1,369,000 | 0.07% |
| MUHLENKAMP & CO INC | 72,786 | $149,000 | 0.05% |
| Orbimed Advisors | 1,799,700 | $3,689,000 | 0.04% |
| MOORE CAPITAL MANAGEMENT, LP | 250,000 | $513,000 | 0.02% |
| Baker Brothers Advisors | 400,000 | $820,000 | 0.01% |